Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in SYNDAX PHARMACEUTICALS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 142,407 shares of SNDX (SYNDAX PHARMACEUTICALS INC), worth $3M as of 2025-Q4. The position was increased (++6.1% shares). SNDX represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$3M
Current Shares
142,407
Total Value Change
-$156,509
Total Shares Change
-10,953
Other major holders of SNDX: BNP PARIBAS FINANCIAL MARKETS
Increased |
| 142,407 |
+6.1% |
| $3M |
| 0.0% |
| $20.74 |
28 |
| 2025-Q3 | Decreased | 134,261 | -47.6% | $2.1M | 0.0% | $15.56 | 0 |
| 2025-Q2 | Increased | 256,138 | +27.6% | $2.4M | 0.0% | $9.04 | 32 |
| 2025-Q1 | Increased | 200,696 | +18.0% | $2.5M | 0.0% | $13.18 | 31 |
| 2024-Q4 | Increased | 170,100 | +23.8% | $2.2M | 0.0% | $12.52 | 32 |
| 2024-Q3 | Decreased | 137,447 | -10.4% | $2.6M | 0.0% | $18.89 | 0 |
| 2024-Q2 | Increased | 153,360 | +58.4% | $3.1M | 0.0% | $20.53 | 38 |